Benjamin Ebert wins the 2021 ASCI/Stanley J. Korsmeyer Award.

CRBN is a substrate receptor for a ubiquitin ligase, so at that stage we thought that lenalidomide was probably an inhibitor of the ubiquitin ligase, as most drugs act as inhibitors. The Journal of Clinical Investigation NEWS 1 Benjamin Ebert wins the 2021 ASCI/Stanley J. Korsmeyer Award Benjamin L. Ebert has been honored by the American Society for Clinical Investigation (ASCI) with the Stanley J. Korsmeyer Award, an annual prize in recognition of outstanding scientific contributions and excellence in mentorship (Figure 1). Instead, CR8 is a molecular glue between a core component of the ubiquitin ligase, the DDB1 adaptor protein, and CDK12, which is not normally part of a ubiquitin ligase. [Extracted from the article]